New ITC Investigation Notices for April 18
The International Trade Commission published notices in the April 18 Federal Register on the following AD/CV injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
Sign up for a free preview to unlock the rest of this article
Communications Daily is required reading for senior executives at top telecom corporations, law firms, lobbying organizations, associations and government agencies (including the FCC). Join them today!
- Notice of the Commission’s Determination Not To Review an Initial Determination Terminating the Investigation on the Basis of Settlement; Termination of the Investigation; Certain Adalimumab, Processes for Manufacturing or Relating to Same, and Products Containing Same (ITC Inv. No. 337-TA-1296) (here)
- Certain Chocolate Milk Powder and Packaging Thereof (ITC Inv. No. 337-TA-1232); Notice of a Commission Determination Not To Review an Initial Determination Granting a Motion To Amend the Complainant and Notice of Investigation and To Review an Initial Determination Extending the Target Date (here)
- Certain Products Containing Pyraclostrobin and Components Thereof (ITC Inv. No. 337-TA-1303); Notice of a Commission Determination Not To Review an Initial Determination Terminating the Investigation in Its Entirety Based Upon a Consent Order Stipulation; Issuance of Consent Orders; Termination of Investigation (here).